Table 2 Number of checks and actions during the 18-month study period for four pharmacotherapeutic categoriesb
Category | Number of prescriptions checked (n) | Number of electronic notes (n (%)) | Number of electronic notes + phone calls (n (%)) |
|---|---|---|---|
Drug use in renal insufficiency | 9381 | 444 (4.7%) | 81 (0.9%) |
Drugs with high potential of QTc prolongation | 4223 | 608 (14%) | 139 (3.3%) |
Drugs with restricted indication or dosing | 5276 | 448 (9%) | 142 (2.7%) |
Overruled very severe DDIs | 18,902 | 939 (5%) | 259 (1.4%) |
Total | 37,782 | 2439 (7%) | 621 (1.6%) |